
Browsing restrictions can be lifted for a fee.
Test Research, Inc. designs, assembles, manufactures, maintains, repairs, and sells automated inspection and testing equipment in Asia, America, Europe, and internationally. The company offers optical inspection solutions, including 3D solder paste inspection, pre-reflow and post- reflow automated optical inspection, and automated X-ray inspection systems; and manufacturing defects analyzers and in-circuit testers. It also provides smart factory and AI-power solutions, as well as yield management system. In addition, the company offers test and inspection solutions for automotive, semiconductor, and telecommunication industries. Further, it provides after sales services, including trouble shooting, failure analysis, periodic calibration, system maintenance, and parts and accessories warranty. Test Research, Inc. was incorporated in 1989 and is headquartered in Taipei City, Taiwan.
3030
德律
-3.81%
(-0.04)
The most recent financial report for 德律 (3030) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3030's short-term business performance and financial health. For the latest updates on 3030's earnings releases, visit this page regularly.
According to historical valuation range analysis, 德律 (3030)'s current price-to-earnings (P/E) ratio is 15.1, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 德律 (3030) reported an Operating Profit of 711.33M with an Operating Margin of 34.18% this period, representing a growth of 50.05% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 德律 (3030) announced revenue of 2.08B, with a Year-Over-Year growth rate of 39.49%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 德律 (3030) held Total Cash and Cash Equivalents of 1.29B, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 德律 (3030) achieved the “three margins increasing” benchmark, with a gross margin of 60.64%%, operating margin of 34.18%%, and net margin of 32.97%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3030's profit trajectory and future growth potential.
According to the past four quarterly reports, 德律 (3030)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.9. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
德律 (3030)'s Free Cash Flow (FCF) for the period is -49.07M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 38.83% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.